Innodata illustrates the importance of the data layer. Its August 6 release reported second-quarter revenue of $92.1 million, up 58% year over year, and described new work involving reinforcement learning for long-horizon and computer-use agents. Yet two customers represented 37% and 34% of quarterly revenue. The company also said its June cash balance included customer prepayments for pass-through costs. Expanding demand for data services therefore needs to be evaluated alongside customer dependence and the distinction between cash received and cash freely available to shareholders.

Cyber resilience is another part of the same ecosystem. Rubrik reported fiscal second-quarter 2027 revenue of $427.3 million, up 38%, and launched Rubrik AI across its security and agent offerings. Its release described autonomous action with guardrails and recovery workflows. That opportunity comes with a financial trade-off: reported free cash flow was $65.7 million, compared with $57.5 million a year earlier, while the company still recorded a GAAP loss per share. More revenue and a broader product range do not automatically settle the question of profitable scaling.

The applications themselves can also provide direct commercial exposure. Duolingo Max offers generative-AI features such as Video Call and Roleplay within a paid subscription tier. Fastly’s AI Accelerator addresses a different problem by caching semantically similar model responses, potentially reducing repeated requests and inference costs. These examples show that an AI business need not own a frontier model. Its opportunity may come from packaging a useful customer experience or making another company’s model cheaper and more practical to use.

Physical devices create a further set of possibilities. Ambarella’s September 3 results described record edge-AI revenue and growth from its CV75 and CV72 chips. The company supplies an AI platform across applications including cameras, vehicle safety and robotics. Meanwhile, IonQ completed its acquisition of semiconductor foundry SkyWater on July 31. SkyWater has described packaging capabilities intended for AI accelerators and high-performance computing. That gives IonQ a separate AI-related infrastructure connection; it does not establish that its quantum-computing research has already become a mature commercial AI business.

Each route has a different way of succeeding and a different way of disappointing investors. Data suppliers must retain demanding customers, security vendors must convert adoption into cash, and chip suppliers must execute product ramps while controlling costs. Businesses with several activities also require care when attributing growth to AI. A strong company-wide sales increase may reflect acquisitions, non-AI products or a small comparison base. The useful question is whether the commercial opportunity can produce durable returns at the price investors pay, rather than whether the company belongs to a fashionable theme.

Zapp2Photo/Shutterstock.com

Our Methodology:

Before collecting financial data, we fixed a 73-stock coverage universe. We required a current U.S.-listed operating company, primary-source documentation of a direct commercial AI product, service or AI-related semiconductor or data-center supply activity, positive trailing revenue, and at least 10% trailing-12-month revenue growth. We limited eligibility to companies held by 50 or fewer hedge funds in Insider Monkey’s Q2 2026 database of 1,006 funds. That threshold is our defined lower-ownership proxy for “overlooked”; it does not measure public awareness or prove that any stock is undiscovered.

Using Stock Analysis income statements accessed on October 3, 2026, we ranked eligible companies by reported whole-company trailing-12-month revenue growth, highest first, and selected 11. Ties would be resolved by greater hedge-fund ownership, then alphabetical ticker order. We imposed no profitability requirement and excluded missing data, companies below the growth threshold, and businesses without verified direct commercial AI exposure. Quantum-machine-learning research alone was insufficient. This defined coverage screen is not an exhaustive search of all AI-related companies.

We display revenue growth and the fiscal period ending the trailing window for every ranked company. These growth figures are not AI-segment growth, organic growth or forecasts; acquisitions and small comparison bases can affect them. IonQ qualifies through the current AI-related packaging activities of its acquired SkyWater subsidiary. Its June 2026 trailing figures predate the July 31 acquisition, and therefore describe its prior business mix rather than SkyWater’s contribution. Quarter-end hedge-fund counts also predate that acquisition. The list counts down from 11 to 1, and “to buy” identifies candidates for further valuation work rather than a promise of investment returns.

11. Dynatrace, Inc. (NYSE:DT)

Number of Hedge Fund Holders: 48

TTM Revenue Growth: 17.94%

Fiscal Period End: June 2026

READ ALSO: Is Dynatrace, Inc. (DT) A Good Stock To Buy Now?

]]> https://www.insidermonkey.com/news/here-is-why-broadcom-avgo-is-a-good-investment-at-todays-price-1848228/ Sun, 04 Oct 2026 20:16:56 +0000 https://www.insidermonkey.com/blog/?p=1848228 Broadcom Inc. (NASDAQ:AVGO) closed at $355.14 on October 2, up 5.86% over twelve months.

The business underneath moved far faster than the share price did. Revenue and earnings both grew at rates most companies never reach. A company almost doubling its sales while the shares barely move is unusual. That gap is the argument here.

READ ALSO: NVIDIA (NVDA) vs. Broadcom (AVGO): Which AI Chip Stock Has the Stronger Moat?

The Market Has Stopped Paying Up for the Growth:

Revenue grew 85.50% in the most recent quarter, and earnings grew 216.10%. Now look at what the market pays for that.

Broadcom trades at 46.50 times trailing earnings and 19.42 times forward estimates. A gap that wide means the market expects reported profit to more than double from here.

The PEG ratio sits at 0.36. That number compares the multiple with the growth rate, and anything under one is normally treated as cheap.

The margins explain why the growth converts. Broadcom keeps 54.31% of revenue as operating profit and 42.94% as net profit, on revenue of $89.1 billion. Return on equity is 44.24%. Few companies of this size earn anything close.

Free cash flow reached $30.6 billion. That covers the $2.60 dividend many times over, which is why the payout ratio is only 32.40%.

DON’T MISS: Marvell vs. Broadcom: Which Custom AI Chip Stock Has More Room to Run?

What the Flat Share Price Is Worried About:

Price-to-book is 17.46, and enterprise value to EBITDA is 33.92. On those measures, nothing about Broadcom is cheap, and the PEG ratio only looks low because the growth rate is extraordinary.

That is the risk in one sentence. The multiple is reasonable against this year’s growth and expensive against any normal year.

Growth of 85.50% comes from a small number of very large customers building AI infrastructure. Orders of that kind arrive in waves rather than streams. Debt is the other item. Broadcom carries $59.42 billion in debt against $23.98 billion in cash, a debt-to-equity ratio of 59.60%.

The cash flow services it comfortably today. It would look different in a year when the orders pause. Billionaire investors rank Broadcom third among semiconductor stocks. Two companies rank above it, and you can see both here.

The Valuation Case:

Sustainability is the whole question. The customers buying this silicon are a handful of very large technology firms, and their spending arrives in build cycles rather than in steady demand.

What is durable is the position. Custom accelerators are designed into a customer’s hardware for years, and switching means redesigning the product around a rival part. On price, the stock is cheap against growth and dear against assets. The PEG ratio of 0.36 and the forward multiple say one thing. Price-to-book of 17.46 says another.

The reconciliation is that Broadcom owns very little physical capital and a great deal of intellectual property, which is what that return on equity describes. The foundry that actually manufactures Broadcom’s chips tops our ranking of the best-performing foreign stocks this year. You can find it here.

Conclusion:

Broadcom earns 54.31% operating margins and 44.24% on equity while sales almost double, and the shares have gone nowhere for a year. However, that growth depends on a handful of AI customers, and the stock is expensive on book value. The number to watch is the forward multiple, because 19.42 times only holds if the earnings arrive.

Market Sentiment:

Broadcom Inc. (NASDAQ:AVGO) was held by 170 hedge funds with a combined stake value of about $29.08 billion at the end of Q2 2026 in the Insider Monkey database. This is down from 173 hedge fund holders with a cumulative investment value of around $32.84 billion in the previous quarter.

[im-yf-promo]

While we acknowledge the potential of AVGO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

[/im-yf-promo]

READ NEXT: “Our Targets Haven’t Changed”: Broadcom’s CEO Pushes Back on the AI Slowdown Scare and Jim Cramer on Broadcom (AVGO): “The Stock May Be Too Cheap to Ignore”

This article is originally published at Insider Monkey.

A strong balance sheet starts with the distinction between resources and promises. Cash and short-term investments provide liquidity, while borrowings and lease obligations create commitments. Inventory and receivables can support working capital, but they do not convert into money on the same timetable as cash. Positive book equity offers another check on the reported financial position. None of these measures guarantees investment success; together, however, they help distinguish a business with financial flexibility from one dependent on its next capital raise.

NAPCO Security Technologies illustrates how operating cash generation can strengthen that flexibility. For its fiscal year ended June 30, 2026, revenue rose 11.4% to $202.3 million and free cash flow reached $59.2 million. Cash and marketable securities totaled $137.6 million. The results also show why investors should look beyond the headline balance: a litigation settlement affected annual earnings, and tariff refunds supported the fourth-quarter gross margin. A substantial cash reserve does not make every improvement recurring.

Energy Recovery provides a different example. Its second-quarter revenue fell approximately 57% to $12 million, and it reported a $3.2 million net loss. Nevertheless, cash, cash equivalents, and investments totaled $98.1 million, including investments outside the short-term category. Its desalination project exposure shows how a company can retain a financial cushion while its customers delay spending. Liquidity gives management time; it does not remove the uncertainty surrounding the timing of future orders.

Capital allocation can change a cushion after the reporting date. Perion ended June with $267.8 million of cash and short-term deposits, down from $312.9 million at year-end. Buybacks and acquisitions require cash even when they are intended to improve future earnings. Its subsequent PRN acquisition carried a purchase price of up to $12 million. Investors therefore need to distinguish the latest reported balance sheet from an estimate of the money available today, especially when evaluating businesses actively buying other companies.

Different business models also complicate comparisons. A payment company needs liquidity to settle transfers, while a manufacturer needs it to cover inventory and production. Consolidated accounts can include subsidiaries that trade separately, creating overlapping exposure for shareholders. Even a high current ratio can reflect slow-moving assets. The useful question is whether financial resources support the business through its own operating cycle, rather than whether one large number makes the company appear universally safer.

For investors considering smaller companies in October, balance-sheet strength is a starting point for further research. Valuation, competitive position, governance, and the durability of cash generation still matter. Financial flexibility can help a company withstand a difficult period and pursue opportunities when competitors retreat. It cannot ensure that the share price will rise.

TaLaNoVa/Shutterstock.com

Our Methodology:

We screened a focused watchlist of 88 US-listed operating companies across technology, manufacturing, distribution, and business services. Market capitalization had to be between $300 million and $2 billion using data available after the October 2, 2026 close. Companies needed positive reported equity, a current ratio of at least 1.5, nonnegative net cash, and positive trailing-12-month free cash flow. Missing comparable data and ceased listings were excluded. This is a screen of that watchlist, rather than a census of every small-cap stock.

We rank qualifying companies by net cash as a percentage of total assets, from highest to lowest, and present the top ten in reverse order. Net cash means cash plus short-term investments less total debt, including vendor-reported lease obligations. The balance-sheet figures are the latest reported period, identified for each entry; they are not estimates of October cash. Free cash flow means operating cash flow less capital expenditure. It is an eligibility condition, as is the current ratio, rather than an additional weighted score. Ties are resolved by higher current ratio, then more hedge fund holders. Stock Analysis supplies the consistent financial fields; company filings and subsequent transaction announcements provide cross-checks.

Hedge fund counts come from Insider Monkey’s Q2 2026 database of 1,006 funds and provide context rather than drive the ranking. Net cash does not mean all liquidity is discretionary: payment settlement obligations matter for Intermex. Perion’s modest post-quarter acquisition does not invalidate the reported-period screen. NLI Holdings, formerly NL Industries, consolidates CompX, so the two entries represent overlapping exposure. Archived standalone analysis links are identified as historical reading and do not supply the current financial inputs.

10. International Money Express, Inc. (NASDAQ:IMXI)

Number of Hedge Fund Holders: 26

Market Capitalization: $347.74 million
Balance-Sheet Period: Jun 2026
Cash and Short-Term Investments: $150.64 million
Total Debt Including Leases: $135.43 million
Net Cash: $15.21 million
Total Assets: $449.64 million
Net Cash / Total Assets: 3.38%
Current Ratio: 1.96
TTM Free Cash Flow: $8.84 million

For the archived investment thesis, READ ALSO: International Money Express (IMXI): A Bull Case Theory

McKinsey’s August 2026 State of AI survey found that 40% of respondents from organizations with more than $1 billion in annual revenue reported scaling AI agents, compared with 27% a year earlier. The comparable share among smaller organizations remained at 22%. These are respondents’ reports about their organizations, rather than a census of all businesses. Even with that limitation, the gap suggests that deployment capacity, integration resources and the scale of potential savings matter alongside model capability.

The spending opportunity also brings competitive pressure. In that survey, 32% of respondents said their organizations had decided against buying at least one software product or feature because agentic coding tools allowed them to build it internally. About 20% reported that AI operating costs constrained usage. Those findings make the investment question sharper: a vendor needs to earn revenue from more automated work while defending its product from cheaper substitutes and keeping the computing bill manageable.

An enterprise agent depends on much more than a capable model. It needs permission to read company information, dependable connections to applications and a way to record what happened. When a process touches customer records, production systems or security settings, mistakes can carry costs well beyond an incorrect answer. That makes identity controls, approval rules, evaluation and observability part of the commercial product. A platform that already holds relevant data and manages the workflow may have an advantage over a new application that requires another integration.

Pricing will determine how much of the productivity benefit suppliers capture. Charging by consumption can benefit from agents that run repeatedly, but customers can reduce usage when bills rise. Charging by completed work can align a product with customer value, although failed tasks, human review and infrastructure still consume resources. Meanwhile, a business built around employee seats has to consider whether greater automation changes the number of paid users. Rising activity does not automatically produce rising profit.

For public-market investors, the cleanest evidence remains commercial availability and companywide financial performance. Agent revenue is often bundled into broader products, making it difficult to isolate its contribution. Positive cash generation can support development and distribution while management tests pricing and demand. It does not establish that an agent business is profitable on its own, and strong revenue growth can reflect acquisitions or products outside AI.

The sector therefore offers several kinds of exposure. Infrastructure providers supply the computing foundation, enterprise platforms organize tasks and specialist vendors help agents operate safely. The investment appeal rests on customers repeatedly paying for useful work, with suppliers retaining enough of that payment to fund the next stage of growth.

Our Methodology:

We screened a defined coverage universe of 20 U.S.-listed companies. This universe covers agent development and deployment platforms, enterprise workflow products and supporting infrastructure; it is a coverage screen rather than an exhaustive inventory of every agentic AI stock. A company had to have an available marketed product or platform supporting enterprise AI-agent development, execution, security, observability or related infrastructure by October 2, 2026. A future product announcement alone did not qualify.

We then required positive year-over-year revenue growth and a positive free-cash-flow margin over the latest reported trailing 12 months available on October 2, plus an exact-ticker match in Insider Monkey’s Q2 2026 hedge-fund worksheet. Free cash flow means operating cash flow less capital expenditure, and its margin is free cash flow divided by revenue. These are consolidated company metrics, not separately reported agentic AI results. Fiscal period endpoints vary and are shown for each stock. Amazon and Oracle failed the cash-flow filter; Synopsys was excluded because general availability of its AgentEngineer solutions and Autopilot Platform was planned for the end of 2026. Seventeen companies remained.

Within that eligible set, we ranked companies by the number of tracked hedge funds holding the stock at June 30, 2026, from highest to lowest, with higher trailing revenue growth breaking equal holder counts. The 11 highest-ranked stocks appear below. The financial filters provide a growth and cash-generation guardrail, while ownership is the ranking spine; this is an institutionally supported shortlist, not a valuation ranking or a forecast of returns. Holder counts describe historical quarter-end ownership and do not measure agentic AI revenue or buying after that date. Missing essential inputs were excluded rather than treated as zero.

11. Adobe Inc. (NASDAQ:ADBE)

Number of Hedge Fund Holders: 81

TTM Revenue Growth: 12.03% | TTM Free-Cash-Flow Margin: 40.79% | TTM Period End: August 2026

READ ALSO: AI Stocks Fell, but Workday and Adobe Jumped. A Favorite AI Disruption Trade Just Flinched

The broader investment case centers on whether Maravai’s proprietary capping technologies and specialized enzyme manufacturing can drive sustained operational leverage as non-COVID biotech R&D spend recovers, expanding gross margins back toward historic norms. Yet, as life science investors look for high-conviction turnarounds, many are asking: could a rival biopharma equipment provider’s strategic subsidiary sale unlock higher margin gains and superior organic growth? Find out here.

Maravai LifeSciences lost $21.6 million in the second quarter, yet more hedge funds are buying in. Those two facts rarely travel together. When the company reported results, it showed a business that is narrowing its losses and raising its profit outlook while still losing money on a GAAP basis. That raises a fair question about what investors are actually paying for.

The Losses Are Shrinking Fast

The clearest bull argument is the swing in profitability. Maravai posted adjusted EBITDA of $8.7 million in the second quarter, against a negative $10.4 million a year earlier, and the net loss narrowed from $69.8 million to $21.6 million. Management then lifted its full-year adjusted EBITDA guidance to a range of $33 million to $35 million, up from $30 million to $32 million. That suggests the improvement is built into the plan rather than being a one-quarter blip.

Underneath sits a moat that is easy to underrate. TriLink is the only company authorized to make CleanCap, a capping technology used in approved COVID vaccines. A second Chinese patent granted on September 29 now protects the cap molecules themselves, not just the methods of making them. Add protection across the US, Europe, Japan and other major markets, plus a licensing offer to developers, and Maravai has a way to get paid as customers’ drug programs advance. The company also opened a GMP enzyme facility, and its ModTail line passed 125 active customers within a year of launch. Still, investors across the healthcare landscape are watching commercial catalysts closely; can new clinical guidelines boost repeat testing volume for a rising diagnostics leader faster than bioprocess suppliers can rebound? Click to read.

Not Every Dollar Repeats

The first complication is that part of this year’s growth was a one-off. Revenue for the first half rose 24.4%, but TriLink’s surge included $14.3 million of large CleanCap orders for COVID vaccine programs in the first quarter. Strip those out, and TriLink’s base growth was 13.4%, which is healthy but a different story from the headline number. Cygnus grew just 2.8% in the second quarter, and part of that came from when Chinese distributors happened to place orders.

The second issue is the quality of the profit story. Adjusted EBITDA is a non-GAAP measure, and after all costs, the company still lost $28.0 million in the first half. Revenue guidance of $205 million to $215 million was reiterated rather than raised, so the better profit outlook arrived without a higher sales target. Anyone buying today is paying for earnings that have not yet reached net income.

Funds Are Leaning In

Some 33 hedge funds now hold Maravai, up from 20 in the prior quarter, so institutions are adding exposure to the turnaround rather than waiting for proof. That begs the valuation question: how much of the recovery is already in the price? With GAAP losses still on the books, an earnings multiple tells you little. The stock is really being valued on whether adjusted EBITDA keeps climbing from the guided range. Short interest stands at 9.84% of float, a real bear camp betting that the COVID-boosted first half flatters the picture. But a clean beat could also force those shorts to cover.

Betting on Timing

Maravai is a stock where the story is improving faster than the financials. Buyers are being asked to believe that shrinking losses will become durable profit before the vaccine-driven boost drops out of the comparison. The bulls need TriLink’s base business to keep compounding and the patent wall to turn into licensing income. The bears need only for growth to cool once large vaccine orders stop. Until one of those happens, the shares are a debate about timing more than quality.

[im-yf-promo]

While we acknowledge the potential of MRVI as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

[/im-yf-promo]

READ NEXT: Top 10 AI Stocks That Will Skyrocket and 2 Stocks Trump Bought in July Are Now Down 17% to 20%. Time to Buy?

Disclosure: None. Follow Insider Monkey on Google News.

While the fundamental narrative is anchored by its status as a direct-to-carrier API platform capturing high-margin CPaaS traffic, the underlying thesis hinges on whether operating leverage can durably turn accelerating top-line expansion into high-quality free cash flow. Yet, as investors weigh its upside, many are asking: could a major network player’s strategic infrastructure dominance give an emerging quantum cloud contender a decisive edge over traditional CPaaS routes? Find out here.

Bandwidth told investors on July 29 that second-quarter revenue climbed 22% to $220 million, and it lifted its full-year outlook again. Reports like that usually push a stock’s price tag out of reach. Yet the shares carry a forward P/E of 23.04, which is a modest multiple for a business growing this fast. The real question is whether that reflects genuine doubt or simple neglect.

Demand Is Doing the Talking

Start with what the growth is doing for profit. Adjusted EBITDA rose 27% to $28 million, and the margin reached a record 18%, so sales are outrunning costs instead of being bought at any price. GAAP net income swung to $2 million from a $5 million loss a year earlier. Management now expects full-year revenue of $900 million to $910 million, which gives the coming quarters a clear target.

The demand story also looks sturdier than one good quarter. Every $1 million-plus win or expansion in the period involved Maestro, Bandwidth’s orchestration platform, or AI services, which suggests the company is selling a bigger product to bigger buyers. One of the largest US text messaging platforms shifted over 95 percent of its text traffic to Bandwidth. Then, on September 15, Bandwidth said it would be the first certified carrier behind the worldwide expansion of the contact center product from Salesforce (NYSE:CRM). That reaches more than 25 countries starting this fall, from Europe to Australia and New Zealand, and it plugs Bandwidth into software enterprises already use. Still, competition in enterprise AI remains fierce: can an established networking giant leveraging deep security acquisitions capture a dominant share of enterprise AI workloads before pure-play voice platforms can scale? Click to read.

Cracks Beneath the Surface

The quality of those earnings deserves a closer look. GAAP gross margin slipped to 36% from 40% a year ago, even as the non-GAAP version edged up to 59% from 58%. That gap means the adjusted picture leans on items the headline numbers leave out. Diluted per-share results were still a loss of $0.07, and non-GAAP earnings of $0.37 per share slipped from $0.38 despite the faster sales. Meanwhile, market dynamics are shifting quickly: is a rising cloud communications rival quietly stealing market share and investor sentiment as Wall Street rediscovers its AI business? Click here to find out.

Cash is not keeping pace either. Free cash flow came in at $24 million against $26 million a year ago, and operating cash flow dipped to $29 million from $32 million. More revenue has not yet become more cash. Third-quarter revenue is guided to $231 million to $235 million, so a company priced on rising profits has little room to stumble. And the Salesforce expansion is still a rollout ahead of us, with no revenue figure attached yet.

Funds Pile In, Shorts Dig

40 hedge funds held Bandwidth in the most recent quarter, up from 21 in the prior one, so institutional ownership nearly doubled. Those buyers are paying a forward P/E of 23.04, as of October 2, which prices the stock on next year’s expected earnings. Set against 22% revenue growth and a full-year non-GAAP earnings guide of $1.71 to $1.79 per share, that multiple asks for steady execution, not heroics. Is that cheap? It depends on whether adjusted earnings turn into cash, which is exactly where the bears are poking. Short interest of 15.69% of float signals heavy skepticism, and it also means good news could force shorts to cover fast.

Where the Math Gets Tricky

Bandwidth’s price tag sits between two readings of the same quarter. One sees an infrastructure provider whose AI-linked wins and Salesforce channel are only starting to show up in the numbers. The other sees adjusted profits that have yet to fully reach cash or per-share earnings. If cash flow starts tracking EBITDA, the multiple looks modest. If it keeps lagging, the market’s caution looks earned.

[im-yf-promo]

While we acknowledge the potential of BAND as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

[/im-yf-promo]

READ NEXT: Top 10 AI Stocks That Will Skyrocket and 2 Stocks Trump Bought in July Are Now Down 17% to 20%. Time to Buy?

Disclosure: None. Follow Insider Monkey on Google News.

Inventiva has no drug on the market and no earnings to price, so what exactly are investors paying for? They are paying for a single answer, due in the fourth quarter of 2026, on whether its liver drug lanifibranor can repeat its early success in a large Phase III trial. Management laid out the stakes on the first-half earnings call on September 28. Almost everything the stock is worth sits on that one readout.

Why Lanifibranor Has Believers

The appeal starts with how the pill works. Lanifibranor is a once-daily tablet that nudges three related receptors, known as PPARs, in a balanced, low-potency way. That lets it go after the liver damage and the metabolic trouble behind MASH at the same time. In the Phase IIb study, six months of treatment lifted fibrosis improvement 18% above placebo, and MASH resolution came in at 26% without fibrosis getting worse. The FDA has also given it Breakthrough Therapy and Fast Track status, a sign regulators see the unmet need too.Phase III is built to test that result at scale.

The main NATiV3 cohort enrolled 1,009 patients with F2 or F3 fibrosis, each treated for 72 weeks. The study is powered at 90% using assumptions that deliberately expect a stronger placebo response and a weaker drug effect than Phase IIb delivered. The prize is large. An estimated 18 million Americans live with MASH, only 10% are diagnosed, and diagnoses are up roughly 25% from 2024. Management sees the field topping $15 billion by 2035, and it is eyeing a follow-on push into advanced disease, where no approved treatment can modify the course.

The Clock on the Cash

The money is the first problem. Inventiva lost €69.5 million in the first half of 2026, and general and administrative costs climbed €7.5 million to €22.2 million as it gears up for a possible launch. Cash and short-term deposits stood at €233.9 million on June 30, after a €103 million share sale and a new debt package of up to €130 million. Even so, that funds operations only through the second quarter of 2027, and management itself said current cash does not cover the next twelve months of planned operations.

Stretching the runway to the first quarter of 2028 requires warrant exercises after positive data and completion of a further debt tranche. That ties the funding to the same readout as the science. The drug itself is not risk-free either. Lanifibranor’s partial activation of one receptor, PPAR gamma, brings weight gain, swelling and a dip in hemoglobin. Those effects are milder than with older drugs in the class, but they are present, and the weight gain levels off only between week 24 and week 30. The company’s LEGEND study found that adding an SGLT2 inhibitor eased the problem. Yet just 10% of NATiV3 participants were taking one at the start, so tolerability is something the Phase III data still has to settle.

Funds Lean In Quietly

Hedge funds holding Inventiva climbed to 35 from 24 in the prior quarter, so more institutions are willing to own the name into the readout. Short interest sits at just 2.18% of float, which suggests little organized money is betting against it. Valuation cannot lean on earnings, since the company lost €69.5 million in six months, so the price is really a bet on probabilities, measured against management’s $15 billion-plus market estimate. Dilution is the obvious worry, but the company bought back about 60% of the anti-dilution warrants held by the European Investment Bank for €50 million and repaid its loans there for €63 million, which removes some of that overhang. Does a rising fund count mean the risk is gone? Not at all, because those investors hold a stock whose runway ends in the second quarter of 2027 without good news.

One Readout, Two Futures

Inventiva is a rare case where a stock’s valuation and its survival plan hinge on the same event. The bulls need Phase III to confirm the fibrosis benefit while tolerability stays manageable, which would open the door to a filing and eventual launch. The bears need only a disappointing result, because the cash runway leaves little room to absorb one. Either way, the answer is due in months, not years. But as clinical-stage biotechs fight to secure their place, could a fast-moving clinical rival end up stealing key star power and dominance in adjacent high-growth metabolic therapies? Click to find out which soaring competitor just posted a massive 35.7% trial-driven rally.

[im-yf-promo]

While we acknowledge the potential of IVA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

[/im-yf-promo]

READ NEXT: Top 10 AI Stocks That Will Skyrocket and 2 Stocks Trump Bought in July Are Now Down 17% to 20%. Time to Buy?

Disclosure: None. Follow Insider Monkey on Google News.

Rosenblatt believes the acquisition could expand AMD’s AI software, modeling, and simulation capabilities at a time when the AI market is developing rapidly and increasingly requires system-level expertise beyond traditional semiconductor capabilities. The deal is valued at $8.2 billion in an all-stock transaction and is expected to close by the end of 2026.

The research firm noted that World Labs’ engineers could help accelerate AMD’s development of AI platforms at the system level while also opening opportunities in new markets such as robotics.

The firm sees the acquisition as bringing forward R&D spending that AMD would otherwise need to undertake to develop this technology in-house. Rosenblatt also approves AMD management’s decision to grow the company’s AI capabilities.

AMD made it to Insider Monkey’s 12 High-Flying Stocks to Invest In. See where it ranks amongst the market’s top performers and which stocks rank ahead.

As part of the transaction, Dr. Fei-Fei Li will join AMD as executive vice president and chief scientist.

Acquisition Adds Long-Term Potential, But Some Concerns Remain

The deal comes with some risks for investors. AMD said it will pay the $8.2 billion purchase price in stock. This means that the transaction will dilute existing shareholders. In addition, the acquisition does not immediately translate into chip revenue or earnings, meaning investors will need to wait for the new capabilities to make meaningful contributions.

The transaction also adds execution and integration risk at a time when AMD’s valuation already reflects substantial expectations for AI-driven growth. As of October 2, the stock has gained more than 180% year-to-date and the company is now valued at more than $1 trillion.

Investors may also want to look at AMD’s $1 Trillion Valuation Raises the Bar for its AI Ambitions.

What the Numbers Say

Hedge fund interest in the stock increased during the second quarter. According to Insider Monkey‘s database, 164 hedge funds held Advanced Micro Devices, Inc. (NASDAQ:AMD) at the end of the second quarter, up from 134 in the first quarter.

It is important to note that AMD does not appear cheap as it trades at a P/E ratio of 156.79. However, this valuation comes alongside substantial earnings and revenue growth. In Q2 2026, AMD’s revenue increased 50% year-over-year to reach $11.5 billion and diluted EPS jumped 156% to $1.38. Data Center revenue also more than doubled from a year earlier.

Management’s outlook points to continued momentum. AMD expects Q3 revenue of approximately $13 billion, which represents about 41% year-over-year growth. This level of growth provides support for AMD’s premium valuation. However, it also means that the stock is already priced for strong execution and continued expansion in AI.

For investors comparing AMD with the leading AI chipmaker, AMD vs. Nvidia: Which AI Stock Is the Better Buy? compares the two companies.

The World Labs acquisition could strengthen the long-term growth story as it strengthens the company’s position in emerging areas such as physical AI, robotics, and spatial computing. However, investors may need to see proof that these capabilities can translate into meaningful financial growth.

[im-yf-promo]

While we acknowledge the potential of AMD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

[/im-yf-promo]

READ ALSO: Target (TGT) Cuts Prices After a Strong Rally. Is the Stock Still Cheap? and Cintas (CTAS) Beats Estimates and Raises Fiscal 2027 Guidance Despite UniFirst Deal Uncertainty.

Disclosure: None. Follow Insider Monkey on Google News.

Lumentum’s fiscal fourth-quarter results, released on August 11, illustrate both sides of that question. Revenue reached $1.006 billion, up 109.3% from a year earlier, while the GAAP operating margin reached 27.8%. Management described optical links moving deeper into data-center architecture and highlighted demand for co-packaged optics lasers, optical circuit switching and faster cloud modules. Its next-quarter revenue outlook was $1.225 billion to $1.275 billion. Those are substantial operating gains, although guidance remains an expectation rather than revenue already earned.

The accounting picture was much less straightforward. Lumentum reported a $7.2 billion quarterly GAAP net loss, largely reflecting a $7.8 billion one-time noncash loss on debt extinguishment related to the equitization of certain amounts of its convertible notes. The company’s $326.3 million non-GAAP net income therefore tells a very different story from its GAAP bottom line. Investors following a rapidly rising stock still need to examine financing transactions, dilution and the adjustments between the two measures, rather than assuming that revenue growth settles every question about earnings quality.

Coherent’s August 12 report provides another example of the operating demand behind the optical trade. Fiscal fourth-quarter revenue was $2.05 billion, up 34% year over year on the reported basis, and GAAP gross margin reached 38.5%. Management cited the transition from copper to optical connectivity in AI data centers and said it was investing to expand manufacturing capacity. More capacity can help satisfy customers, but the investment case still depends on executing that expansion without allowing costs, production delays or competitive pricing to erode the benefit.

The opportunity also extends beyond physical infrastructure. CrowdStrike reported fiscal second-quarter 2027 revenue of $1.47 billion, up 26%, and annual recurring revenue of $5.84 billion as of July 31. It generated $377.4 million of free cash flow while recording a $33.2 million GAAP operating loss. Its product announcements included security for AI-agent identities and runtime detection and response for AI agents. That combination shows why software growth, cash generation and accounting profitability deserve separate attention even when the same AI theme connects them.

For investors, the common challenge is separating a business opportunity from an attractive entry price. A company can grow quickly while its shares fall if expectations were higher still. Manufacturing suppliers face order timing and capacity risks; software vendors face competition and changing customer budgets. Past price strength helps identify where enthusiasm has concentrated, but it does not establish fair value or guarantee another strong year. The stocks below provide a starting point for examining that distinction, with the underlying company analyses offering the fuller investment cases.

asharkyu/Shutterstock.com

Our Methodology:

We established a 60-stock coverage universe spanning technology, AI infrastructure, power, software and selected consumer businesses before collecting the ranking data. This is a defined, technology-heavy coverage screen, not an exhaustive search of every listed stock.

Eligible companies had to be currently U.S.-listed operating common shares or ADRs with a positive, comparable 52-week share-price change and an exact-ticker match in Insider Monkey’s hedge-fund database. Using Stock Analysis statistics for the completed October 2, 2026 session, we ranked eligible companies by 52-week share-price change, highest first, and selected the top 12. Ties would be resolved by greater hedge-fund ownership, then alphabetical ticker order. We imposed no earnings or cash-flow filter. The gains measure share prices, exclude dividends, and are not total returns or forecasts.

The list counts down from 12 to 1 and displays the controlling price-change metric for every company. Hedge-fund figures are reportable long positions in Insider Monkey’s Q2 2026 database, covering 1,006 funds. They are historical quarter-end snapshots, not evidence that managers endorsed subsequent price gains. “High-flying” describes observed momentum; “to invest in” identifies research candidates rather than a conclusion that their current valuations are attractive.

12. Palo Alto Networks, Inc. (NASDAQ:PANW)

Number of Hedge Fund Holders: 89

52-Week Share-Price Change: 94.99%

READ ALSO: Palo Alto Networks (PANW) Is a Good Business. But Can Its Growth Justify the Valuation?

]]> https://www.insidermonkey.com/news/10-high-beta-stocks-with-strong-revenue-growth-1847951/ Sun, 04 Oct 2026 18:10:27 +0000 https://www.insidermonkey.com/blog/?p=1847951 High-beta growth stocks bring together two different kinds of momentum: expanding businesses and share prices that have historically reacted strongly to the broader market. In October 2026, that combination spans memory chips, AI infrastructure, enterprise software, quantum computing, and commercial space. These businesses can grow much faster than mature industries while still exposing investors to sharp changes in expectations, financing conditions, and the price paid for future earnings.

Beta describes a stock’s historical sensitivity to market returns. A reading above one indicates that its returns have tended to amplify movements in the benchmark; it does not predict the next day’s price change. FINRA distinguishes this measure from the risks specific to an individual company. An earnings disappointment, delayed product, or costly acquisition can affect a stock even when the market is relatively stable. Strong revenue growth therefore provides business context, rather than protection against a falling share price.

Micron illustrates how powerful a demand cycle can become. Its fiscal 2026 revenue reached $133.19 billion, compared with $37.38 billion a year earlier, in results released on September 30. Fourth-quarter revenue alone was $54.23 billion, up from $11.32 billion. Those figures show the scale of the memory expansion, but they also establish a much larger comparison base for the coming year. Sustaining a strong business does not necessarily mean repeating the same percentage growth.

Smaller markets can produce even larger growth rates without producing profits. IonQ reported second-quarter revenue of $80.1 million, up 287% from a year earlier. Its filing attributes the increase to progress on specialized quantum-computing hardware arrangements and contributions from acquisitions. The company also reported an adjusted EBITDA loss of $120.3 million, a non-GAAP measure. Commercial expansion and spending on a developing platform are occurring together, making sales growth only one part of the investment case.

Space technology presents another version of that tension. Rocket Lab’s second-quarter revenue rose 62% to approximately $234 million, while its backlog reached $2.36 billion. The company nevertheless recorded a quarterly net loss of about $49.3 million. Its August update targeted delivery of Neutron to the launch pad in the fourth quarter; that milestone should not be confused with a completed inaugural launch. The difference between booked demand, delivered hardware, and recognized profit remains economically significant.

Comparisons also require care. Acquisition-driven revenue is different from growth generated by existing operations, and a twelve-month growth rate is different from a single quarter’s acceleration. A company with a small starting revenue base can post spectacular percentages while retaining substantial funding needs. A larger company may grow more slowly in percentage terms while adding far more revenue in dollars. Neither historical beta nor sales growth establishes whether today’s valuation leaves room for execution setbacks.

The useful question is whether business expansion is creating durable value at a price investors can tolerate. Cash conversion, dilution, customer concentration, and the cost of reaching scale can change the answer even when revenue continues rising. High-beta stocks with strong sales momentum offer exposure to ambitious industries, but the path from growing demand to attractive shareholder returns can remain uneven.

An analyst studying a graph of a company’s asset value and potential cash flow.

Our Methodology:

We established a research universe of 30 U.S.-traded operating companies and ADRs spanning semiconductors, AI infrastructure, enterprise software, quantum computing, lending technology, and space systems. This is a defined technology-oriented screen, rather than a census of every high-beta stock.

We defined high beta as a reported five-year beta strictly above 1.50 and strong revenue growth as at least 20% over the trailing twelve months. We used Stock Analysis statistics and financial tables available after the October 2, 2026 market close, alongside exact ticker matches in Insider Monkey’s Q2 2026 database of 1,006 hedge funds. Companies missing an essential input were excluded. Thirteen companies qualified. Negative free cash flow was permitted because this screen measures historical sales expansion and market sensitivity, rather than profitability.

We selected the ten qualifying companies with the highest trailing-twelve-month revenue growth, ranking that single factor in descending order. Ties would go to higher hedge-fund ownership and then higher free-cash-flow margin. Beta determines eligibility rather than adding a second ranking weight, and no normalization or composite score is needed. Entries display the reported two-decimal growth rate, five-year beta, financial period, and hedge-fund count. Financial periods vary with fiscal calendars; ownership is a June 30 snapshot. Growth is reported consolidated growth, including acquisitions where applicable, rather than an organic or pro-forma measure. The ranking does not imply that the fastest-growing company is cheapest or safest.

10. Advanced Micro Devices, Inc. (NASDAQ:AMD)

Number of Hedge Fund Holders: 164

Five-Year Beta: 2.45

Trailing-Twelve-Month Revenue Growth: 39.54%

Financial Period: June 2026

For the investment case behind the growth figures, READ ALSO: AMD and Intel Soared as Nvidia Lagged: Has the AI Trade Changed?

]]> https://www.insidermonkey.com/news/10-stocks-with-low-debt-and-strong-free-cash-flow-1847931/ Sun, 04 Oct 2026 18:04:43 +0000 https://www.insidermonkey.com/blog/?p=1847931 Low debt and strong free cash flow give a company room to keep investing when demand weakens, financing becomes less attractive or competitors need to conserve cash. That flexibility can fund product development, protect a dividend or support a repurchase without depending on a favorable bond market. For shareholders, the harder question is whether the cash-producing business also comes at a price that leaves room for a satisfactory return.

Cash generation needs to survive the spending required to maintain the business. Free cash flow generally starts with operating cash flow and subtracts capital expenditure. A software company collecting subscription payments, a chip designer outsourcing production and a footwear company managing inventory can all generate it, but the underlying risks differ. Upfront customer collections can lift one period’s cash flow; delayed investment can make another look stronger than its long-term economics justify.

Fortinet’s second-quarter 2026 results illustrate the difference between reported earnings and spendable operating cash. The cybersecurity company generated $1.044 billion of operating cash flow and spent $78 million on property and equipment, leaving $965.6 million of free cash flow. That equaled 47.2% of quarterly revenue. Its separately adjusted figure was higher, at $995.9 million, because it added back real-estate purchases. Investors comparing businesses should preserve the ordinary capital-expenditure deduction rather than mix adjusted and unadjusted measures.

The balance sheet provides a second check. Fortinet reported approximately $2.935 billion of cash and $1.135 billion of short-term investments at June 30. A cash reserve can cushion weaker collections and support investment, but cash cannot be considered independently of debt, lease obligations and future commitments. Gross debt still matters even when liquid assets exceed it, because maturities, restrictions and the location of cash can affect how readily a company meets its obligations.

Recent corporate events can also make an attractive historical balance sheet misleading. Vertex reported $13.6 billion of cash, cash equivalents and total marketable securities at June 30, then completed its Crinetics acquisition on September 1. The transaction’s announced equity value was approximately $10 billion, with planned funding combining cash and debt. Vertex said it would explain the accounting and financial impact with third-quarter results. Its earlier cash position therefore cannot establish the company’s post-acquisition leverage.

Valuation is the final distinction. A high free-cash-flow margin shows that a business retains a substantial portion of sales after capital spending. A high free-cash-flow yield shows that the business generates a larger amount of trailing cash flow relative to the equity price investors pay.. The two can disagree: an exceptional business may carry a demanding valuation, while a cheaper stock may face slowing demand or a deteriorating competitive position.

Financial strength also does not eliminate dilution, product risk or poor capital allocation. Stock-based compensation can support operating cash flow while increasing the share count, and buybacks do not create value automatically. The useful opportunity is a business that can finance its obligations and reinvestment internally, with sustainable cash generation that reasonably supports its market value. Low leverage provides flexibility; disciplined spending and the purchase price determine how much of that flexibility benefits shareholders.

Our Methodology:

We screened 42 U.S.-traded nonfinancial common stocks and ADRs spanning technology, healthcare, consumer products and industrial businesses. This is a defined coverage screen, rather than an exhaustive survey of the stock market.

Eligibility required gross total debt no greater than 20% of total assets, net debt no greater than one times positive trailing EBITDA, trailing free-cash-flow margin of at least 10%, and an exact-ticker hedge-fund count from Insider Monkey’s Q2 2026 worksheet. Net debt is total debt less cash and short-term investments, floored at zero for net-cash companies. Debt includes lease obligations in the consistently applied financial-data provider’s totals. Ratios use the same reporting currency. Financial inputs come from Stock Analysis’s latest reported statements and statistics available on October 2, 2026. We exclude missing required inputs and completed material debt-financed acquisitions where the earlier balance sheet cannot establish current eligibility. Vertex was excluded on this basis after its Crinetics acquisition. Sixteen companies qualified.

We ranked the eligible companies using equal 50% weights for trailing free-cash-flow margin and free-cash-flow yield, with the weights fixed before gathering inputs. Free cash flow is operating cash flow less capital expenditure; margin divides it by revenue, while yield divides it by equity market capitalization at the October 2 close. We consistently use the provider’s reported two-decimal percentages. Each becomes a 0–100 percentile across the 16 companies, with higher values scoring better, ties receiving their average rank and endpoints separated by 15 rank intervals. Composite ties break on Q2 hedge-fund holders, then margin. We selected the top 10, displaying scores and leverage ratios to two decimals. Selected periods end in June 2026, except NVIDIA’s July period. Holder counts describe June 30 positions, not current sentiment. Nearby weighting choices can change order and final inclusion; trailing cash flow is not a forecast or a return guarantee.

10. Palantir Technologies Inc. (NASDAQ:PLTR)

Number of Hedge Fund Holders: 86

Total Debt / Total Assets: 1.81%

Net Debt / TTM EBITDA: 0.00x

TTM Free Cash Flow Margin: 54.55%

TTM Free Cash Flow Yield: 0.74%

Composite Score: 50.00

Fiscal Period End: June 2026

READ ALSO: Is Palantir’s Cash Flow Keeping Ahead of Share Dilution?

]]> https://www.insidermonkey.com/news/inspire-medical-insp-how-much-optimism-is-baked-into-this-medtech-stock-1847843/ Sun, 04 Oct 2026 17:44:08 +0000 https://www.insidermonkey.com/blog/?p=1847843 Inspire Medical Systems (NYSE:INSP) demonstrates strong core gross economics with a 85.5% gross margin, $415.2 million in cash and investments, and a raised 2026 revenue guidance range of $835 million to $875 million. The company centers on its expanded patient reach, with over 140,000 patients treated, and its high-margin Inspire V system driving operational cash flow, offsetting short-term top-line headwinds while it works to secure long-term reimbursement clarity. However, as Inspire faces transitional coding hurdles, can a dominant sector titan leverage its category leadership to capture expanding market share despite rising competitive pressures? Find out here.

Inspire Medical Systems makes an implant for obstructive sleep apnea, and its sales are shrinking. Yet the stock trades at a forward P/E of 59.17, a multiple usually reserved for companies in the middle of a sprint. The company announced on October 1 that the AMA’s CPT Editorial Panel had approved new billing codes covering its latest device, a reimbursement milestone investors have been waiting on. The real question is how much of that good news the price already counts as banked.

Fatter Margins, Fresher Cash

The new Category I codes cover the Inspire V system and take effect on January 1, 2028. Dedicated codes should give hospitals and physicians a cleaner path to billing, which management expects to cut paperwork and widen patient access. Medicare still has to set a payment value for each code, and the company expects CMS to publish a proposed valuation in July 2027, with final numbers in November 2027. That matters because the US sales decline has been tied to a shifting coding and reimbursement environment.

Underneath, the business looks healthier than the top line suggests. Gross margin rose 150 basis points to 85.5% in the second quarter as more sales shifted to Inspire V, which earns more per device than its predecessor. Operating cash flow hit $23.2 million, up from $2.7 million a year earlier, helped by better handling of receivables and inventory. The company also raised its 2026 revenue outlook to a range of $835 million to $875 million, and it holds $415.2 million in cash and investments. Add more than 140,000 treated patients, and this is a company with a proven product, not one guessing at demand.

Meanwhile, as investors evaluate shifted product mixes across the sleep apnea device landscape, is a powerful market leader seeing its core business boom even as one key product stumbles? Click to read.

Shrinking Sales Meet Rich Pricing

Revenue fell 7.6% to $200.6 million in the second quarter. The US drove the decline, and international growth only partly cushioned it. Profit is razor-thin, with an operating loss of $0.5 million and GAAP diluted EPS of just $0.01. Management leans on adjusted EPS of $0.14, but the gap between adjusted and reported results deserves a close look. The company’s own full-year GAAP EPS guidance runs from a loss of $0.42 to a profit of $0.17, a range that straddles zero.

Fixing the business also costs money and time. Project Horizon, the restructuring plan, carries $20 million to $25 million of pre-tax charges and aims to free up roughly $30 million a year for growth spending. That only pays off if the redeployed dollars actually restart US sales. And with pricing for the new codes unsettled until late 2027, the reimbursement fog may linger for a while.

Skeptics Hold the Microphone

Hedge fund ownership slipped to 32 funds from 42 in the prior quarter, so institutions have been trimming rather than building positions. The forward P/E of 59.17, as of October 2, explains much of the hesitation. At that level, buyers are paying today for earnings that have not shown up yet, and with reported profit near zero, the multiple only works if you trust adjusted earnings, which the company guides at $1.05 to $1.45 for 2026.

Why would funds walk away from a company with margins this strong? Because a premium price leaves no room for sales to keep sliding while the reimbursement picture clears. Short interest sits at 17.79% of float, which signals heavy skepticism. It also means a crowded bet that could snap higher quickly if the news flow improves, though some of that shorting may be hedging rather than outright conviction.

Priced for a Turnaround

Inspire has strong gross economics, a clearer reimbursement road map, and a stock priced as if the road is already paved. The tension is timing, since the revenue decline is happening now while the payoff from the new codes sits well down the line. Bulls need US sales to stabilize and the reallocated restructuring dollars to earn a real return. Bears are watching for the CMS valuation to disappoint and for earnings to stay too thin to support the multiple.

[im-yf-promo]

While we acknowledge the potential of INSP as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

[/im-yf-promo]

READ NEXT: Top 10 AI Stocks That Will Skyrocket and 2 Stocks Trump Bought in July Are Now Down 17% to 20%. Time to Buy?

Disclosure: None. Follow Insider Monkey on Google News.

IDT used to be a story about a shrinking international calling business. When it reported fiscal 2026 results on September 28, the more interesting number was 53%. That is the share of consolidated adjusted EBITDA, before corporate overhead, that now comes from three growth segments making up just a third of revenue. Management is guiding to $176 million to $180 million of adjusted EBITDA for fiscal 2027, so the real question is whether the stock’s price already reflects that handoff.

The Better Businesses Take Over

Start with margins, because that is where quality shows up. Fourth-quarter revenue rose 7% to $339.0 million, and gross margin widened 360 basis points to 39.8%. The extra sales are coming from richer businesses, not cheaper ones. National Retail Solutions/NRS, its point-of-sale business for independent retailers, is the clearest example. Revenue jumped 31% to $45.0 million while adjusted EBITDA climbed 47%, and its Rule of 40 score, which adds growth to profit margin, rose to 60 from 49 a year earlier.

Fintech and net2phone are following the same script. At BOSS Money, the remittance app, 88% of transactions now start in IDT’s own apps, and that shift helped lift the Fintech segment’s gross margin by 650 basis points to 65.6%. net2phone, the cloud communications arm, ended the year with 447,000 seats, up 6%, and management says it is on track to pass $100 million in annual recurring revenue in the current quarter. Adjusted EBITDA there rose 26% to $4.4 million even as IDT spent on AI products, a sign the segment is gaining operating leverage while it invests.

Meanwhile, in the broader mobile network landscape, could an aggressive 5G expansion give a key player the ultimate edge over an established global rival? Click to read.

Cracks in the Old Engine

The old business is still the bigger business, and parts of it are eroding. In the fourth quarter, Traditional Communications brought in $222.0 million of revenue, up 2%, but BOSS Revolution calling revenue fell 10%. A new federal tax on cash-originated remittances also hit the retail side of money transfers, where revenue from the retailer agent channel dropped 17%. Management argues that every customer who moves to the app is more profitable, and the Fintech margins support that. But it does mean a tax, not just customer preference, is speeding the migration.

Some of the recent strength also deserves a closer look. NRS’s fourth-quarter gross profit and adjusted EBITDA got a lift from a one-time import tariff refund, so management points to the full-year gross margin of 92% as the cleaner read. At net2phone, subscription revenue grew 10%, but only 7% excluding currency effects, so exchange rates flattered the headline. NRS also depends on independent store operators, whom management describes as working in a very tough environment. And the fiscal 2027 targets rely on every segment contributing more.

Quiet Funds, Quiet Shorts

25 hedge funds hold IDT, down from 26 the quarter before, a shift too small to read as a verdict either way. Short interest is 3.50% of float, so few investors are betting against the story. The valuation question then comes down to how you weigh two halves of the company. The legacy segment still produced $19.9 million of adjusted EBITDA in the fourth quarter, up 12%, and management calls it a cash generator for years, which helps fund the growth units. IDT also holds $271.9 million in cash and liquid investments with no debt, so the balance sheet softens the downside. What does that leave the price to pay for? Mainly for IDT delivering the 15% adjusted EBITDA increase it is guiding to at the midpoint.

As investors weigh recurring cash generators against subscriber gains, can an industry titan sustain both its strong cash flow and subscriber momentum to win the market? Click to see.

The Rotation Is the Whole Story

IDT is turning into a different company than its revenue line suggests, and the open question is how fast the new mix can outgrow the old one. Bulls need the margin gains at NRS, BOSS Money, and net2phone to hold once one-time boosts like the tariff refund fall away. Bears will be watching whether calling and retail remittances shrink faster than cost cuts can cover. The next few quarters of segment results will show which view the numbers lean toward.

[im-yf-promo]

While we acknowledge the potential of IDT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

[/im-yf-promo]

READ NEXT: Top 10 AI Stocks That Will Skyrocket and 2 Stocks Trump Bought in July Are Now Down 17% to 20%. Time to Buy?

Disclosure: None. Follow Insider Monkey on Google News.

Vail Resorts reported fiscal 2026 results on September 28, and the headline numbers look rough. Net income fell to $147.5 million from $280 million a year earlier, after snowfall and snowpack in the Rockies sank to or near historic lows. But management is guiding to a rebound, so the stock comes down to how much of that rebound you believe.

A Cushion Built Before Winter

The best argument for Vail is that the business bent without breaking. Lift revenue slipped only 3.5% in a winter that kept plenty of skiers home, because so many guests had already paid for passes before the first snowflake fell. Resort reported EBITDA still landed at $745.7 million. The company also squeezed out $45 million in savings from its efficiency overhaul in fiscal 2026 and raised its annualized target to $110 million by the end of fiscal 2027.

Fiscal 2027 guidance assumes normal weather, with net income of $158 million to $233 million and resort EBITDA of $805 million to $865 million. Management points to history, where US ski visits tend to bounce back fast after a bad year. It also reads part of the pass weakness as lower-commitment guests delaying decisions rather than walking away. Those guests could still show up as lift ticket buyers once the snow is real. Meanwhile, in adjacent high-yield sectors, investors are asking: could a rapidly expanding rival’s growth trajectory turn key industry partnerships into an even bigger catalyst for momentum stock market dominance? Find out here.

Margins Still Slide Downhill

The pass numbers are the hard part. Units are down about 12% as of September 18, and sales dollars are down 6%, with the damage concentrated in destination frequency passes. Management is not counting on improvement during the rest of the selling season, and it says US visitation will not fully return to fiscal 2025 levels. The CEO also called the hangover from last winter a genuine risk, and a slowdown in high-end travel would pile on.

Even if guests come back, profitability gets squeezed. Guidance implies a resort EBITDA margin of 27.3% before one-time costs, about 200 basis points below the original fiscal 2026 plan. Costs are rising roughly 4% from wages, utilities, and fuel. Another $20 million comes from restoring incentive pay and $10 million from extra marketing. Leverage stood at 3.9 times trailing EBITDA as of July 31, 2026, and the path down to 3.5 times assumes net debt holds steady.

Skeptics Crowd the Chairlift

Hedge fund interest cooled a bit, with 40 funds holding the stock in the latest count versus 45 in the prior one. Short interest is far louder at 29.16% of the float, which signals heavy doubt but also a crowded bet that could snap back if results cooperate. At 21.93 times forward earnings, as of October 2, the shares are priced on the expected recovery rather than on last year’s $147.5 million. Is that a bargain or a trap? It hinges on whether earnings land inside the guided range, because a second weak winter would make that multiple look rich fast.

Dividend holders get some comfort, since management expects positive free cash flow after capital spending and dividends even at the low end, including the $2.22 payout due October 27 to holders of record on October 8. As cash-flow stability remains top of mind for income investors, can a dominant sector titan convert higher average revenue per user into dramatically bigger cash flow to outshine its peers? Click to see.

Where the Trail Splits

The tension is that the price leans on a normal winter while the guidance leaves little slack for soft pass sales and rising costs. Bulls need the snow and the late-deciding skiers to arrive, while bears need cautious guests and steady inflation to keep eating into margins. With so much stock sold short, the market is watching closely for which way it goes.

[im-yf-promo]

While we acknowledge the potential of MTN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

[/im-yf-promo]

READ NEXT: Top 10 AI Stocks That Will Skyrocket and 2 Stocks Trump Bought in July Are Now Down 17% to 20%. Time to Buy?

Disclosure: None. Follow Insider Monkey on Google News.

However, with the stock trading near historical valuation highs, market watchers are questioning whether macro shifts could disrupt this premium. Did Jim Cramer’s recent tactical shift around Costco signal a broader strategic change for the warehouse giant? Click to find out.

Costco closed out fiscal 2026 with an earnings call on September 24, and the report read like a company with nothing left to prove. Net sales reached $93.87 billion, up 11.2%, and net income landed at $2.998 billion. The business keeps compounding, which is exactly why the price tag deserves a harder look.

Why Members Keep Coming Back

Membership is the engine, and it is running hot. Costco now counts 84.1 million paid members, and 42.3 million of them pay for the higher Executive tier, a group that grew 9.4% and pushed that tier’s share of the base to a new high. Renewal rates ticked up to 92.3% in the US and Canada and 89.8% worldwide, so the base is sticking, not just growing. Membership fee income rose 7.3% to $1.849 billion, the steady profit stream sitting behind those low shelf prices.

The runway looks long, too. Management plans 33 openings in fiscal 2027 as it works toward 30 net new warehouses a year, and the shopper mix is getting younger. Members under 40 have grown nearly 60% since the pandemic and now make up more than a quarter of the base. Digitally enabled sales topped $33 billion with growth above 20%, while pharmacy grew nearly 20% and gas, travel, and cruises all pulled their weight. Shoppers also visited 3.3% more often, which means the ancillary businesses are adding reasons to walk through the door.

While Costco’s volume growth remains impressive, investors are closely watching head-to-head metrics against nimble competitors: is a rising retail rival quietly stealing market share and key star power from big-box leaders? Click to read. Furthermore, following a strong earnings print, valuation debates remain front and center: why did top analysts trim price targets even after a quarterly beat? Find out here.

Where the Cracks Could Show

The quarter was not spotless. Reported gross margin slipped to 11.02% from 11.13% a year earlier, as gas and digital sales outgrew core merchandise. Lower overhead covered the gap, with SG&A falling to 8.94% of sales, but that cushion relies on volume staying strong. Inflation is creeping in as well. The LIFO charge jumped to $152 million from $43 million, which the CFO tied to pricier memory in electronics and Middle East conflict costs for gas, motor oil, and resins.

Earnings quality also needs a careful read. Tariff refunds added $0.15 per share, and the $184 million received covers only about a third of the expected recovery, with management already spending part of it on cuts to Kirkland Signature items like coffee and black pepper. Growth is getting pricier too. Capital spending ran $6.4 billion in fiscal 2026, and the guide for fiscal 2027 is roughly $7.5 billion as the pipeline of new buildings fills up.

What the Market Is Paying

Hedge fund ownership slipped to 104 funds from 107, a small trim rather than an exodus, but notably not the accumulation you might expect after a report this strong. The forward P/E of 40.32 is the heart of it. You are paying about $40 for every $1 of earnings expected over the next year, which means years of steady membership growth, warehouse openings, and margin discipline are already baked into the price. That is a fair bet on a business with renewal rates this high, but it leaves little room for a stumble, since a slowdown in openings or a squeeze on margins would hit the multiple as well as the earnings.

Short interest sits at just 1.66% of the float, so almost nobody is betting against the business itself. Skeptics here are objecting to the price, not the operation, and when optimism is this widely shared, there is less cushion if the story wobbles. What does that multiple actually ask of a new buyer? Patience measured in years, and an expectation that the compounding keeps going without interruption.

The Real Debate

Costco’s operating story and its valuation are pulling in different directions, and neither side has cracked the other yet. The bulls need membership loyalty and the expansion plan to keep delivering so earnings grow into the premium. The bears need only to see margin pressure and rising costs outrun the operating leverage, because a multiple this high gives growth very little room to disappoint.

[im-yf-promo]

While we acknowledge the potential of COST as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

[/im-yf-promo]

READ NEXT: Top 10 AI Stocks That Will Skyrocket and 2 Stocks Trump Bought in July Are Now Down 17% to 20%. Time to Buy?

Disclosure: None. Follow Insider Monkey on Google News.

On September 24, Scholastic reported a first quarter that looked rough on paper. Revenue slipped 4% to $216.8 million, and the net loss came to $71.2 million, or $3.77 per share. Yet management left its full-year targets untouched. Whether that gap reflects a seasonal dip or something deeper is the heart of the valuation debate.

A Fall Stacked With Hits

The first quarter is the quietest stretch of Scholastic’s year, with schools largely out of session. Last year it made up only 14% of full-year revenue, so judging the company on it is a bit like judging a ski resort in July. The real test is the fall, and early signals lean the right way. Book Fairs are off to a better start than last year, with bookings and the number of fairs both higher, and the business is reaching new school communities, including Christian schools. Management also points to strong operating leverage here, which means each additional fair should drop more profit to the bottom line.

Then there is the content. The HBO adaptation of Harry Potter arrives this Christmas, and the company is pushing readers to pick up the first book before the show airs. Dog Man, which has more than 70 million books in print worldwide, gets a new title in November, the same month a Hunger Games film lands. Entertainment is already showing a spark, with revenue up 48% to $20.1 million on heavier production activity. Clifford’s YouTube views rose 52% ahead of a PBS KIDS series planned for 2027, which suggests the characters still pull an audience.

The balance sheet adds some cushion. Net debt fell to $86.8 million from $242.8 million a year earlier, mostly thanks to the sale-leaseback deals completed in December 2025, and the company still bought back $25.8 million of its own stock during the quarter. Meanwhile, as traditional publishers navigate seasonal swings, could this multi-year operational turnaround offer a faster path to multi-year outperformance? Find out here.

The Quarter Nobody Bragged About

The losses were not all seasonal noise. Education revenue fell $9.7 million to $30.4 million as districts juggled higher staffing costs and the end of ESSER pandemic relief funding in March. Management expects that segment to improve only as the year goes on, and mostly in the second half. Overhead also climbed $5 million to $23.3 million, and international operations face rising fuel and freight costs that management expects to leave that segment’s operating income modestly lower for the year, even with revenue growth.

The sale-leaseback that cleaned up the debt came with a price tag. It erased rental income and added rent expense, and free cash use for the quarter was $110.8 million, worse than last year’s $100.2 million. That makes the full-year targets a steep climb. Adjusted EBITDA of $135 million to $145 million and free cash flow of $35 million to $40 million both have to be built on top of a first-quarter adjusted EBITDA loss of $63.6 million. Nearly everything rides on the holiday season delivering.

Paying Up Against the Shorts

Hedge fund ownership edged up to 23 funds from 21 in the prior quarter, a modest vote of confidence from professional money even after a messy print. The valuation is where the real debate sits. At 22.17 times forward earnings, as of October 2, you are paying today for profits that have not shown up yet, so the multiple only works if the fall and holiday stretch convert into the earnings that number assumes. That leaves little room for a stumble from a company that just posted a $71.2 million quarterly loss.

Buybacks cut both ways here: fewer shares outstanding make per-share earnings easier to grow, but they also magnified this quarter’s per-share loss, and $157.4 million of authorization remains. Meanwhile, 18.01% of the float is sold short, which is heavy skepticism. Those bets lose badly if the fall delivers, since covering could fuel a sharp rally. But they look smart if the guidance slips, so who is right before the holidays is the one question that matters.

Where the Evidence Splits

Scholastic is a stock where the multiple and the calendar are pulling against each other. What investors are paying for sits in the fall and holiday season, while the numbers on the page come from the quietest quarter of the year. The bull case works if Book Fairs and the franchise releases turn that seasonal setup into real profit. The bear case works if Education softness and rising costs keep eating into the gains. The next few quarters will show which side the earnings land on.

[im-yf-promo]

While we acknowledge the potential of SCHL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

[/im-yf-promo]

READ NEXT: Top 10 AI Stocks That Will Skyrocket and 2 Stocks Trump Bought in July Are Now Down 17% to 20%. Time to Buy?

Disclosure: None. Follow Insider Monkey on Google News.

Accenture reported fourth-quarter results on October 1 that beat its own revenue guidance, and yet the shares carry a forward P/E of just 12.41. For a consulting giant growing in every region and still shrinking its share count, that is a strikingly low valuation. What does the market see that management does not?

Demand Keeps Showing Up

Fourth-quarter revenue came in at $18.7 billion, up 7% in local currency, and the growth was not confined to one corner. Every geography and both consulting and managed services expanded at that same pace. More telling is what clients signed: bookings of $22.2 billion outran revenue, so the pipeline is refilling faster than the company is working it off. Managed services, the multiyear outsourcing side, set a fourth-quarter record at $12.8 billion. That is sticky work, and it makes future revenue easier to predict.

The AI story supports the numbers rather than threatening them, at least on management’s telling. Accenture ended the fiscal year with nearly 110,000 AI and data professionals, well past the 80,000 it had targeted. More than 400 clients began advanced AI projects during fiscal 2026, and nearly 100 of those arrived in the fourth quarter alone. Bookings from its eight emerging AI and data partners more than tripled. Leadership argues that the new work AI creates is bigger than the efficiency it takes away, and revenue per person rose during the year, which hints that productivity gains are landing in the company’s favor. But as enterprise technology budgets get reallocated toward high-impact digital transformation, market watchers continue to question: how defensible is this consulting power’s economic moat, and is it actually widening or narrowing in the face of next-generation software tools? Click here to find out.

Then there is the cash. Free cash flow reached $11.6 billion for the year, about 1.4 times net income, so reported profits are backed by real money. The company returned $11.5 billion to shareholders, split between $7.5 billion of buybacks and $4 billion of dividends. It plans to send back at least $9.5 billion in fiscal 2027, and a quarterly dividend of $1.71 per share, up 5%, is already declared.

Where the Pressure Hides

The growth engine is slowing, and acquisitions are doing some of the lifting. Fiscal 2027 guidance calls for 3% to 6% revenue growth in local currency, with 2% to 2.5% of that bought rather than built. Fiscal 2026 offers a preview, since 5% reported growth contained only about 3% organic. Earnings per share are guided to climb 3% to 6%, a step down from the 8% adjusted gain this year. And management plans roughly $5 billion in new deals on top of the Cyber OT purchases that closed in September 2026, so integration risk is growing alongside the bill. Meanwhile, investors looking at quarter-over-quarter execution are asking: can record AI bookings and stellar Q4 earnings continue to crush disruption fears and drive double-digit stock rallies? Find out here.

Outside pressures are real too. Middle East weakness, worth roughly $1 billion of annualized revenue, got worse in the fourth quarter. Management also saw lower pricing in many parts of the business, a sign that rivals are fighting hard for contracts. Consulting bookings only matched revenue, and clients’ discretionary spending did not meaningfully change. The low end of the fiscal 2027 range explicitly leaves room for that spending to weaken. Meanwhile, the federal business, which wound down at the end of the third quarter, dragged full-year growth by about 1 percentage point.

Cheap for a Reason?

Hedge fund ownership rose to 69 funds from 64 in the prior quarter, so a few more professionals are willing to own Accenture at today’s price. Short interest of 4.53% of float points to a real but modest bear camp, not a crowded bet against the company. The harder question is whether a forward P/E of 12.41, as of October 2, is a bargain or a warning. It says investors are paying little for growth, which fits guidance of 3% to 6% earnings gains and the open question of how much AI efficiency eats into the business. But that multiple also sits on top of heavy free cash flow, and a share count management expects to fall about 3%, which cushions per-share results even if revenue stalls. Is the discount too deep for a company still booking more work than it bills?

The Gap Worth Watching

The market seems to have stopped giving Accenture credit for steady execution, even as clients keep signing more work than the company delivers. The tension is whether a low multiple reflects slowing, partly acquired growth or simply a gloomy reading of AI. The bull case needs organic growth to hold while buybacks and AI-heavy deals nudge margins higher. If pricing pressure and soft discretionary spending keep biting, the bears will have the better argument.

[im-yf-promo]

While we acknowledge the potential of ACN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

[/im-yf-promo]

READ NEXT: Top 10 AI Stocks That Will Skyrocket and 2 Stocks Trump Bought in July Are Now Down 17% to 20%. Time to Buy?

Disclosure: None. Follow Insider Monkey on Google News.

This cash-generative engine underpins a compelling thesis that market skepticism over near-term integration friction and top-line deceleration creates a disconnect against the company’s compounding earnings power. Yet, while Progress focuses on extracting value from mature software platforms, a rapidly expanding rival is quietly capturing high-growth enterprise market share and siphoning key talent; click here to see which stock is stealing market momentum.

Progress Software just closed the largest acquisition in its history, and the stock’s price tag looks like it belongs to a company in trouble. Revenue is slipping, and debt is rising. Yet profit margins are fat, and cash keeps rolling in. Is the market being too harsh, or is it seeing something the headlines hide?

Profits Keep Outrunning Sales

When Progress reported its third quarter on September 30, 2026, it showed a company shrinking at the top and thriving underneath. Revenue slipped 2% to $246 million, but non-GAAP earnings per share rose 13% to $1.69. The reason is cost control. Expenses fell about 6%, pushing operating margin to 43% from 40% a year earlier, so profit is coming from running lean rather than from selling more.

Cash backs that up. Adjusted free cash flow grew 17% to $87 million as customers paid faster, with days sales outstanding dropping to 42 from 73 at the end of fiscal 2025. That points to the billing backlog from the ShareFile integration being cleared out. The extra cash funds debt paydown, $170 million so far this year, plus $17 million of buybacks in the quarter. But while Progress turns off-the-radar acquisitions into cash flow machines, a fast-moving cybersecurity competitor is winning key enterprise matchups and rapidly expanding automated solutions; read more here to find out who is outpacing the market.

Then there is Domo. Progress paid $400 million, which works out to 1.4 times revenue and 3.5 times pro forma EBITDA on management’s steady-state numbers. Management expects Domo to add well over $100 million in annual EBITDA once integration finishes by the end of fiscal 2027, and more than 85% of Domo’s ARR already comes from consumption-based contracts that retain customers better. Buying that kind of earnings power at that price is the heart of the bull argument. Meanwhile, another industry peer continues to raise the bar with double-digit growth numbers of its own; click to read which rising rival is quietly outperforming expectations.

The Bill Comes Due

Growth is the soft spot. ARR rose only about 1% on a pro forma basis and net retention sits at 99%, so the core business is holding steady rather than compounding. Domo is shrinking by design too. Its roughly $300 million annualized top line is expected to settle between $280 million and $290 million as seat-based customers churn or convert and services work moves to partners. Management expects heavy attrition in that seat-based book because AI agents are taking over tasks people used to do.

Then there is the funding. Progress drew $390 million on its revolver, leaving total debt near $1.24 billion and net leverage around 2.7 times. Formal fiscal 2027 guidance comes in January, but management already warned that Domo will run slightly below a 30% operating margin while synergies ramp. That would pull Progress’s overall margin to 36% to 37% from its usual 38% to 39%, with roughly $21 million of added interest expense on top. SaaS offerings also carry slightly lower gross margins, a possible drag as that mix grows. Management says the squeeze reverses once synergies arrive.

Cheap But Unloved

Hedge fund holders fell to 23 from 29 in the prior quarter, so institutions are trimming as the Domo debt comes aboard. Short sellers hold 16.69% of the float, which signals heavy skepticism and also sets up a sharp squeeze if the news turns. Against that sits a forward P/E of 6.47, as of October 2, meaning investors pay about $6.47 for each dollar of expected earnings. For a business that just posted a 43% operating margin, that is a steep discount, and it suggests the market either expects earnings to shrink or doubts they will last.

What could justify the doubt? Flat ARR, leverage, and seat-based churn are the obvious candidates, and the fiscal 2027 margin dip gives skeptics near-term ammunition. But management still expects fiscal 2027 to bring substantial earnings growth because Domo’s earnings exceed the interest cost of funding it, so the multiple already reflects plenty of worry about integration.

Where The Debate Lands

Progress is a high-margin, cash-rich business priced as if its best days are behind it, and the evidence does not settle which view is right. The bull side needs Domo’s consumption base to hold its customers and the EBITDA target to arrive on schedule. The bear side needs only churn that runs deeper than planned, or an integration that drags longer than expected. Retention data after Domo joins the reported numbers will say more than any single multiple can.

[im-yf-promo]

While we acknowledge the potential of PRGS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

[/im-yf-promo]

READ NEXT: Top 10 AI Stocks That Will Skyrocket and 2 Stocks Trump Bought in July Are Now Down 17% to 20%. Time to Buy?

Disclosure: None. Follow Insider Monkey on Google News.

Read also: Is SPGI’s dividend growth worth its low starting yield? 

FactSet just posted the largest quarterly jump in contract value it has ever recorded, yet the stock changes hands at a forward P/E of 13.95. That gap is what makes this one interesting. Either the market doubts the growth will last, or it is pricing in a threat from AI to the data business. Management’s September 30 earnings call gave both camps plenty to work with.

Growth That Finally Showed Up

Annual subscription value, the forward-looking revenue from current subscriptions, grew 7% organically to $2.568 billion in fiscal 2026, beating the top of management’s own guidance. The fourth quarter added $86 million by itself. Retention held above 95%, which means clients are staying while new business piles on, and every region grew faster than it did a year earlier. Asia Pacific led at 10.6%.

The AI story matters even more for the long-term picture. AI-related products made up at least 10% of new subscription value in the fourth quarter, more than all of fiscal 2025 combined. Clients using those offerings grew their spending twice as fast as everyone else, and over 650 of them were already tapping FactSet data through its MCP servers. Contracts are also getting longer, with average renewal length up roughly 30% as the company shifts from per-seat deals to enterprise agreements, and pricing was broadly preserved.

Where The Margin Squeeze Bites

Growth came at a cost. Full-year adjusted operating margin slipped 1.8 percentage points to 34.5%, partly from heavy spending on infrastructure and cybersecurity. Faster sales also hurt in the short run, because bonus costs hit the income statement immediately while the revenue they generate arrives slowly. Management is calling this year’s margin a floor and guiding to a modest recovery, but the target range only wins back a slice of what was lost. Additional headcount cuts in September will also weigh on near-term free cash flow.

Next year’s outlook is less exciting than this year’s results. Organic subscription growth is guided to 5% to 6.5%, below the 7% just delivered, and management has not baked in any AI-driven acceleration. Earnings per share guidance of $19.25 to $19.65 absorbs a roughly 2% drag from higher taxes and interest, partly because $500 million of 2.9% notes mature in March 2027. An undrawn revolver, expanded to $1.5 billion, softens that blow. Usage-based AI revenue could also make results lumpier than the steady subscriptions investors are used to.

While FactSet works through these short-term margin pressures, a fast-moving rival is quietly poaching key institutional clients and capturing lucrative market share with a lower-cost, highly aggressive data platform.

Cheap On Paper, Crowded Shorts

In the most recent quarter, 47 hedge funds held FactSet, up from 39 in the prior one, so institutional money is moving in rather than out. At a forward P/E of 13.95, as of October 2, investors pay 13.95 times next year’s expected earnings. That is a modest price for a business with retention above 95%, free cash flow up 14.6% to $707.5 million, and a share count cut by nearly 7% through buybacks. Slower guided growth explains part of the discount, but probably not all of it. The rest looks like a bet that AI agents eventually shrink the demand for data terminals, and short sellers holding 12.43% of the float are making that bet with real money. Is the discount a bargain or a warning? Heavy short interest cuts both ways, since a stumble validates the bears, while good news can force a scramble to cover. The November 10 Investor Day, where management plans to lay out its multiyear targets, is the next test.

What Has To Go Right

The tension is whether FactSet’s early AI results mark a stronger franchise or a temporary lift before agents erode the need for its products. Bulls need consumption-based AI revenue to reach reported results and margins to climb back from this year’s low. The bear case gains ground if enterprise deals start costing pricing power, or if restructuring savings never reach operating profit.

[im-yf-promo]

While we acknowledge the potential of FDS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

[/im-yf-promo]

READ NEXT: Top 10 AI Stocks That Will Skyrocket and 2 Stocks Trump Bought in July Are Now Down 17% to 20%. Time to Buy?

Disclosure: None. Follow Insider Monkey on Google News.

Jabil has spent years shedding its image as a plain contract manufacturer, and its Sept. 30, 2026 earnings call made the case that the makeover is paying off. Fourth-quarter revenue jumped 29% year over year, and core earnings per share rose 34% to $4.40. Management then guided fiscal 2027 core EPS to $17.55, another gain of about 34%. The business is clearly accelerating, but what investors are willing to pay for that acceleration is the more interesting story. Yet, as hardware demand surges across hyperscale networks, will another key supplier steal the spotlight in optical connectivity after a major sector giant’s recent plunge? Read more here.

More Than a Server Builder

The engine is AI infrastructure. Jabil generated $14.4 billion of AI-related revenue in fiscal 2026 and expects $22.1 billion in fiscal 2027, a 54% increase. What makes that easier to believe is where the demand comes from. Management says most of it supports inference, the everyday running of existing models, rather than the race to train frontier systems, and direct exposure to frontier developers is a small fraction. Usage-driven demand needs storage, networking, power, and cooling, not just accelerators, and Jabil now builds across all of it. Six customers in the segment are expected to top $1 billion each in fiscal 2027.

The second leg is how efficiently growth turns into cash. Jabil supported $36.0 billion of revenue in fiscal 2026 on just $470 million of net capital spending, which is why core return on invested capital sits at 59%, nearly triple the fiscal 2020 level. Free cash flow beat the company’s own early target, and management plans to return at least 80% of it to shareholders over time. Buybacks absorbed about $1.1 billion of that in fiscal 2026.

Where the Plan Could Slip

Growth at this pace has to be physically built, and supply is the choke point. Francis McKay, the chief supply chain officer, said memory is being pulled toward AI and hyperscale buyers, squeezing the other markets Jabil serves. That already shows up in guidance, where Connected Living is expected to shrink 15% to $2.3 billion, partly because management is cautious about memory and partly because it is exiting lower-complexity programs. Healthcare also fell short of expectations in the fourth quarter, thanks to equipment delays and a customer program that slipped.

Execution and concentration come next. Jabil is adding more than $8.5 billion of revenue in fiscal 2027, which management itself called unprecedented, and a second hyperscale customer is expected to pass 10% of total revenue, a mark only one customer reached two years ago. Net inventory days of 64 still sit above the 55 to 60 day target, so working capital has to tighten while the factories scale. Management also raised the question of AI volatility on the call, arguing that its inference-heavy mix is steadier.

What the Multiple Says

Hedge fund interest ticked higher, with 69 funds holding Jabil against 67 in the prior quarter, so institutions are adding rather than heading for the exits. Short interest of 3.24% of float is low, which signals little organized betting against the story. The forward P/E of 19.34, as of October 2, is where the real debate sits. Earnings are guided to grow about 34% in fiscal 2027, so a multiple under 20 leaves little growth premium in the price, and the market appears to want proof before paying for it. Is that caution fair? An inference-heavy mix and a share count cut by 49% since fiscal 2013 argue for some support under the stock. But a modest multiple only looks cheap if the earnings arrive, and memory supply and the capacity buildout are the two things that could delay them.

The Capacity Question

Jabil’s story comes down to whether its new factory space fills on schedule. The evidence shows a company growing fast, generating cash and trading at a multiple that does not demand perfection. Bulls need committed customer programs to keep ramping into the capacity already built. Bears need only a memory shortage or a stumbled launch to show how much.

[im-yf-promo]

While we acknowledge the potential of JBL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

[/im-yf-promo]

READ NEXT: Top 10 AI Stocks That Will Skyrocket and 2 Stocks Trump Bought in July Are Now Down 17% to 20%. Time to Buy?

Disclosure: None. Follow Insider Monkey on Google News.